Gyre Therapeutics, Inc.

NASDAQ:GYRE

Biotechnology

Healthcare
$4.34 -0.15%

+$0.00 today

Market cap
$475.02M
Beta
4.92
P/E (TTM)
-88.3
EPS (TTM)
-$0.07
52W Low $5.44High $9.42

Volume 0.47M

Average 0.09M

Balance Sheet

Inspect the capital base behind the business.

Assets

$166.13M

FY 2025 · Annual

+32.5% YoY

Liabilities

$23.85M

FY 2025 · Annual

-11.7% YoY

Equity

$142.28M

FY 2025 · Annual

+44.6% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents44.35M25.18M33.51M11.81M37.07M
Short-term Investments2.5M0014.86M15.36M
Net Receivables1.82M15.61M16.84M29.15M36.95M
Inventory06.12M4.28M6.34M10.17M
Other Current Assets2.81M2.37M1.05M1.44M2.83M
Total Current Assets51.48M49.65M57.22M64.79M102.37M
Property, Plant & Equipment (Net)3.71M18.38M23.78M25.7M24.73M
Goodwill00000
Intangible Assets01.86M1.7M1.71M4.73M
Long-term Investments07.39M23.43M24.57M0
Tax Assets004.7M5.62M6.87M
Other Non-current Assets472K7.48M5.72M3.03M27.43M
Total Non-current Assets4.19M35.1M59.32M60.62M63.76M
Total Assets55.66M84.75M116.54M125.41M166.13M
Account Payables6.42M122K355K108K124K
Short-term Debt1.98M0000
Tax Payables005.05M2.83M2.94M
Deferred Revenue230K079K156K111K
Other Current Liabilities4.07M4.86M648K5.7M2.67M
Total Current Liabilities14.17M12.24M20.05M19.52M18.29M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00213K928K852K
Other Non-current Liabilities0173K82.13M5.68M4.41M
Total Non-current Liabilities408K294K82.54M7.49M5.56M
Total Liabilities14.57M12.54M102.59M27M23.85M
Common Stock31K64K77K86K91
Retained Earnings(402.69M)10.06M(85.54M)(73.45M)(68.43M)
Accumulated OCI40.23M(392K)1.45M501K2.32M
Other Stockholders Equity000090.91K
Minority Interest029.7M29.78M35.08M36.25M
Total Equity41.09M72.22M13.95M98.4M142.28M
Total Debt2.39M613K409K1.6M939K
Net Debt(41.96M)(24.56M)(33.1M)(10.22M)(36.13M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$37.5M
Short-term Investments$12.3M
Receivables$22.8M
Inventory$11.4M
Other Current$7.8M
Total Current Assets$91.7M
PP&E (Net)$23.6M
Intangible Assets$4.6M
Long-term Investments$31.0M
Tax Assets$7.7M
Other Non-current$3.3M
Total Non-current Assets$70.3M
Total Assets$162.0M

Analysis

Selected assets total $162.0M for Latest. The largest visible component is Cash & Equivalents at $37.5M, about 23.1% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 6, 2026
8-KCurrent reportNov 5, 2026
8-KCurrent reportOct 22, 2026
8-KCurrent reportSep 1, 2026
S-8S-8 filingAug 27, 2026

How much cash does GYRE have?

Gyre Therapeutics, Inc. (GYRE) reported $37.07M in cash and equivalents in fiscal 2025.

How much debt does GYRE carry?

Gyre Therapeutics, Inc. (GYRE) reported $939,000.00 of total debt, with net debt of -$36.13M.